Beatrice Tazza
Overview
Explore the profile of Beatrice Tazza including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
92
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tazza B, Caroccia N, Toschi A, Pascale R, Gkrania-Klotsas E, Navarro P, et al.
Clin Microbiol Infect
. 2025 Feb;
PMID: 39954948
Objectives: Our aim was to address existing knowledge gaps regarding risk stratification, best use of diagnostic resources, optimal treatment and general management of SARS-CoV-2 infection in solid organ transplant (SOT)...
2.
Pascale R, Tazza B, Amicucci A, Salvaterra E, Dolci G, Antonacci F, et al.
Transpl Int
. 2024 Sep;
37:13245.
PMID: 39220301
Perioperative antibiotic prophylaxis (PAP) in lung transplant recipients (LuTRs) has high heterogeneity between centers. Our aim was to investigate retrospectively the approach to PAP in our center over a 20-year...
3.
Rinaldi M, Bartoletti M, Bonazzetti C, Caroccia N, Gatti M, Tazza B, et al.
Int J Antimicrob Agents
. 2023 Oct;
62(6):106998.
PMID: 37838147
Background: Intra-abdominal candidiasis (IAC) has a high mortality rate. However, the correct management of a critically ill patient with suspected IAC remains unclear. The aim of this study was to...
4.
Rinaldi M, Campoli C, Gallo M, Marzolla D, Zuppiroli A, Riccardi R, et al.
BMC Infect Dis
. 2023 Oct;
23(1):646.
PMID: 37784051
Purpose: To investigate the clinical impact of three available antivirals for early COVID-19 treatment in a large real-life cohort. Methods: Between January and October 2022 all outpatients tested positive for...
5.
Masetti M, Scuppa M, Aloisio A, Giovannini L, Borgese L, Manno S, et al.
Microorganisms
. 2023 Mar;
11(3).
PMID: 36985328
Patients with heart transplantation (HT) have an increased risk of COVID-19 disease and the efficacy of vaccines on antibody induction is lower, even after three or four doses. The aim...
6.
Gatti M, Bonazzetti C, Tazza B, Pascale R, Miani B, Malosso M, et al.
Clin Microbiol Infect
. 2023 Mar;
29(9):1150-1158.
PMID: 36894053
Background: The clinical usefulness of follow-up blood cultures (FUBCs) in gram-negative bloodstream infections (GN-BSIs) represents a debated issue. Objective: To assess the impact on the clinical outcome of FUBCs in...
7.
Vetrugno L, Castaldo N, Fantin A, Deana C, Cortegiani A, Longhini F, et al.
Pulmonology
. 2023 Jan;
29(6):457-468.
PMID: 36669936
Background: The risk of barotrauma associated with different types of ventilatory support is unclear in COVID-19 patients. The primary aim of this study was to evaluate the effect of the...
8.
Bonazzetti C, Tazza B, Gibertoni D, Pasquini Z, Caroccia N, Fani F, et al.
Clin Infect Dis
. 2023 Jan;
76(10):1761-1767.
PMID: 36636955
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination in solid organ transplant (SOT) recipients is associated with poorer antibody response (AbR) compared with non-SOT recipients. However, its impact on...
9.
Reyna-Villasmil E, Caponcello M, Maldonado N, Olivares P, Caroccia N, Bonazzetti C, et al.
Biomedicines
. 2022 Oct;
10(10).
PMID: 36289699
The objective of this study was to assess the association between patients’ epidemiological characteristics and comorbidities with SARS-CoV-2 infection severity and related mortality risk. An umbrella systematic review, including a...
10.
Bussini L, Testi D, Tazza B, Oltolini C, Mastaglio S, Sepulcri C, et al.
EJHaem
. 2022 Oct;
PMID: 36248618
Efficacy of early treatment with anti-SARS-CoV-2 spike protein monoclonal antibodies (mAbs) for nosocomial SARS-CoV-2 infection in hematologic patients is unknown. Retrospective, cohort study conducted in four Italian teaching hospitals. We...